Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Progyny, Inc.NASDAQ: PGNY

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin widens to 8.0%

Net margin was 8.0% in Q2 FY2026, up 2.9 pp from a year earlier. On a trailing-twelve-month basis it was 6.0%, up 1.7 pp year over year. Over 3 fiscal years it widened by 0.7 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 7 analysts of 8.5% for the fiscal year ending Dec 2026, up from 4.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.0%+0.6 pp QoQ
Last fiscal yearDec 2025
4.5%-0.1 pp YoY
LTMJun 2026
6.0%+1.7 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.9 pp+3.0 pp+0.2 pp
1 year-0.1 pp+4.0 pp+4.1 pp
3 years+0.7 pp+5.4 pp+4.7 pp
5 years+5.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
4.5%
Year-over-year change
-0.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 net margin of 6.0% is the 2nd highest of the 3 companies compared; the peer median is 7.6%.
  • Its year-over-year change of +1.7 pp is the lowest of 3, against a peer median of +11.7 pp.
  • Over three fiscal years its change of +0.7 pp compares with a peer median of +47.9 pp.
PGNY Competitors Peer median
Net Margin for PGNY and competitors
Company Period LTM level YoY 3-year change
HQYHealthEquity, Inc.LTM Jul 202617.4% +5.9 pp+19.4 pp
PGNYProgyny, Inc.LTM Jun 20266.0% +1.7 pp+0.7 pp
OMDAOmada HealthLTM Mar 2026-2.2% +17.6 pp+76.4 pp
Peer median (excluding PGNY) 7.6%+11.7 pp+47.9 pp

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue500.62M786.91M1.09B1.17B1.29B
Cost of Revenue388.49M619.59M849.8M913.86M984.18M
Gross Profit112.14M167.33M238.8M253.36M304.48M
Gross Margin22.4%21.3%21.9%21.7%23.6%
Research & Development00000
Selling, General & Admin79.8M143.98M176.62M185.91M219.21M
Operating Expenses79.8M143.98M176.62M185.91M219.21M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
EBITDA33.74M26.04M72.97M86.38M100.38M
EBITDA Margin6.7%3.3%6.7%7.4%7.8%
Operating Income32.34M23.34M62.18M67.46M85.28M
Operating Margin6.5%3.0%5.7%5.8%6.6%
Interest Income461K814K8.51M15.75M10.16M
Interest Expense00000
Other Income / Expenses95K1.1M8.51M15.75M10.16M
Income Before Tax32.44M24.44M70.69M83.2M95.43M
Pre-Tax Margin6.5%3.1%6.5%7.1%7.4%
Income Tax Expense(33.33M)(5.92M)8.65M28.87M36.91M
Net Income65.77M30.36M62.04M54.34M58.52M
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (Basic)0.740.330.650.590.68
EPS (Diluted)0.660.300.620.570.65
Weighted Avg Shares89.11M92.2M95.02M91.48M85.23M
Weighted Avg Shares (Diluted)100.36M99.96M100.67M95.45M89.46M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.